Literature DB >> 32210765

CD8 T-cell Recruitment Into the Central Nervous System of Cuprizone-Fed Mice: Relevance to Modeling the Etiology of Multiple Sclerosis.

Mohammed S M Almuslehi1,2, Monokesh K Sen1, Peter J Shortland3, David A Mahns1, Jens R Coorssen4,5.   

Abstract

Cuprizone (CPZ)-feeding in mice induces atrophy of peripheral immune organs (thymus and spleen) and suppresses T-cell levels, thereby limiting its use as a model for studying the effects of the immune system in demyelinating diseases such as Multiple Sclerosis (MS). To investigate whether castration (Cx) can protect the peripheral immune organs from CPZ-induced atrophy and enable T-cell recruitment into the central nervous system (CNS) following a breach of the blood-brain barrier (BBB), three related studies were carried out. In Study 1, Cx prevented the dose-dependent reductions (0.1% < 0.2% CPZ) in thymic and splenic weight, size of the thymic medulla and splenic white pulp, and CD4 and CD8 (CD4/8) levels remained comparable to gonadally intact (Gi) control males. Importantly, 0.1% and 0.2% CPZ were equipotent at inducing central demyelination and glial activation. In Study 2, combining Cx with 0.1% CPZ-feeding and BBB disruption with pertussis toxin (PT) enhanced CD8+ T-cell recruitment into the CNS. The increased CD8+ T-cell level observed in the parenchyma of the cerebrum, cerebellum, brainstem and spinal cord were confirmed by flow cytometry and western blot analyses of CNS tissue. In Study 3, PT+0.1% CPZ-feeding to Gi female mice resulted in similar effects on the peripheral immune organs, CNS demyelination, and gliosis comparable to Gi males, indicating that testosterone levels alone were not responsible for the immune response seen in Study 2. The combination of Cx+0.1% CPZ-feeding+PT indicates that CPZ-induced demyelination can trigger an "inside-out" immune response when the peripheral immune system is spared and may provide a better model to study the initiating events in demyelinating conditions such as MS.
Copyright © 2020 Almuslehi, Sen, Shortland, Mahns and Coorssen.

Entities:  

Keywords:  atrophy; castration; demyelination; gliosis; gonadally intact; inside-out; peripheral immune organs

Year:  2020        PMID: 32210765      PMCID: PMC7076139          DOI: 10.3389/fncel.2020.00043

Source DB:  PubMed          Journal:  Front Cell Neurosci        ISSN: 1662-5102            Impact factor:   5.505


  90 in total

Review 1.  Experimental Autoimmune Encephalomyelitis (EAE) as Animal Models of Multiple Sclerosis (MS).

Authors:  Simon Glatigny; Estelle Bettelli
Journal:  Cold Spring Harb Perspect Med       Date:  2018-11-01       Impact factor: 6.915

2.  Augmentation of T cell levels and responses induced by androgen deprivation.

Authors:  Anja C Roden; Michael T Moser; Samuel D Tri; Maria Mercader; Susan M Kuntz; Haidong Dong; Arthur A Hurwitz; David J McKean; Esteban Celis; Bradley C Leibovich; James P Allison; Eugene D Kwon
Journal:  J Immunol       Date:  2004-11-15       Impact factor: 5.422

3.  Proliferation and death of oligodendrocytes and myelin proteins are differentially regulated in male and female rodents.

Authors:  Mirela Cerghet; Robert P Skoff; Denise Bessert; Zhan Zhang; Chadwick Mullins; M Said Ghandour
Journal:  J Neurosci       Date:  2006-02-01       Impact factor: 6.167

4.  Biochemical effects of cuprizone on mouse liver and heart mitochondria.

Authors:  C L Hoppel; B Tandler
Journal:  Biochem Pharmacol       Date:  1973-09-15       Impact factor: 5.858

5.  Effects of orchiectomy on spleen cell mitogen response and on the thymus of aged mice.

Authors:  D H Dean; R N Hiramoto; V K Ghanta; N S Hiramoto; C N Wall
Journal:  Exp Aging Res       Date:  1984       Impact factor: 1.645

6.  Toxicity of cuprizone a Cu(2+) chelating agent on isolated mouse brain mitochondria: a justification for demyelination and subsequent behavioral dysfunction.

Authors:  Mehrdad Faizi; Ahmad Salimi; Enayatolla Seydi; Parvaneh Naserzadeh; Mehdi Kouhnavard; Atena Rahimi; Jalal Pourahmad
Journal:  Toxicol Mech Methods       Date:  2016-04-18       Impact factor: 2.987

Review 7.  Therapeutic approaches in multiple sclerosis: lessons from failed and interrupted treatment trials.

Authors:  Heinz Wiendl; Reinhard Hohlfeld
Journal:  BioDrugs       Date:  2002       Impact factor: 5.807

8.  Giant hepatic mitochondria: production in mice fed with cuprizone.

Authors:  K Suzuki
Journal:  Science       Date:  1969-01-03       Impact factor: 47.728

9.  Higher Serum Immunoglobulin G3 Levels May Predict the Development of Multiple Sclerosis in Individuals With Clinically Isolated Syndrome.

Authors:  Stephanie Trend; Anderson P Jones; Lilian Cha; Scott N Byrne; Sian Geldenhuys; Marzena J Fabis-Pedrini; William M Carroll; Judith M Cole; David R Booth; Robyn M Lucas; Allan G Kermode; Martyn A French; Prue H Hart
Journal:  Front Immunol       Date:  2018-07-13       Impact factor: 7.561

10.  HTLV-1 HBZ Protein Resides Exclusively in the Cytoplasm of Infected Cells in Asymptomatic Carriers and HAM/TSP Patients.

Authors:  Greta Forlani; Marco Baratella; Alessandra Tedeschi; Claudine Pique; Steve Jacobson; Roberto S Accolla
Journal:  Front Microbiol       Date:  2019-04-26       Impact factor: 5.640

View more
  10 in total

1.  Cuprizone feeding induces swollen astrocyte endfeet.

Authors:  Petra Fallier-Becker; Irina Bonzheim; Friederike Pfeiffer
Journal:  Pflugers Arch       Date:  2022-10-15       Impact factor: 4.458

2.  Siponimod ameliorates metabolic oligodendrocyte injury via the sphingosine-1 phosphate receptor 5.

Authors:  Newshan Behrangi; Leo Heinig; Linda Frintrop; Emily Santrau; Jens Kurth; Bernd Krause; Dimitrinka Atanasova; Tim Clarner; Athanassios Fragoulis; Markus Joksch; Henrik Rudolf; Sven G Meuth; Sarah Joost; Markus Kipp
Journal:  Proc Natl Acad Sci U S A       Date:  2022-09-26       Impact factor: 12.779

3.  Histological and Top-Down Proteomic Analyses of the Visual Pathway in the Cuprizone Demyelination Model.

Authors:  Mohammed S M Almuslehi; Monokesh K Sen; Peter J Shortland; David A Mahns; Jens R Coorssen
Journal:  J Mol Neurosci       Date:  2022-05-30       Impact factor: 2.866

4.  Oligodendrocyte-Specific Mechanisms of Myelin Thinning: Implications for Neurodegenerative Diseases.

Authors:  Monokesh K Sen; Md Jakir Hossain
Journal:  Front Neurosci       Date:  2021-03-24       Impact factor: 4.677

Review 5.  Therapeutic Potentials of Poly (ADP-Ribose) Polymerase 1 (PARP1) Inhibition in Multiple Sclerosis and Animal Models: Concept Revisiting.

Authors:  Yan Wang; David Pleasure; Wenbin Deng; Fuzheng Guo
Journal:  Adv Sci (Weinh)       Date:  2021-12-21       Impact factor: 17.521

Review 6.  Ponesimod in the Treatment of Relapsing Forms of Multiple Sclerosis: An Update on the Emerging Clinical Data.

Authors:  Serena Ruggieri; Maria Esmeralda Quartuccio; Luca Prosperini
Journal:  Degener Neurol Neuromuscul Dis       Date:  2022-03-22

7.  Cuprizone-induced Demyelination in Mouse Brain is not due to Depletion of Copper.

Authors:  Megan L Morgan; Wulin Teo; Yda Hernandez; Craig Brideau; Karen Cummins; Hedwich F Kuipers; Peter K Stys
Journal:  ASN Neuro       Date:  2022 Jan-Dec       Impact factor: 5.200

Review 8.  Pre-clinical and Clinical Implications of "Inside-Out" vs. "Outside-In" Paradigms in Multiple Sclerosis Etiopathogenesis.

Authors:  Haley E Titus; Yanan Chen; Joseph R Podojil; Andrew P Robinson; Roumen Balabanov; Brian Popko; Stephen D Miller
Journal:  Front Cell Neurosci       Date:  2020-10-27       Impact factor: 5.505

9.  Revisiting the Pathoetiology of Multiple Sclerosis: Has the Tail Been Wagging the Mouse?

Authors:  Monokesh K Sen; Mohammed S M Almuslehi; Peter J Shortland; Jens R Coorssen; David A Mahns
Journal:  Front Immunol       Date:  2020-09-29       Impact factor: 7.561

Review 10.  The roles of microglia and astrocytes in phagocytosis and myelination: Insights from the cuprizone model of multiple sclerosis.

Authors:  Monokesh K Sen; David A Mahns; Jens R Coorssen; Peter J Shortland
Journal:  Glia       Date:  2022-02-02       Impact factor: 8.073

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.